SEARCH RESULTS for assignee:"regenxbio"

Showing 1 to 4 of 4 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 16093363: Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF Fab

(A1) 20190127455: Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF Fab

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15574432: INTRANASAL THERAPEUTIC DELIVERY OF ADENO-ASSOCIATED VIRUS TO CENTRAL NERVOUS SYSTEM

(A1) 20180289839: INTRANASAL THERAPEUTIC DELIVERY OF ADENO-ASSOCIATED VIRUS TO CENTRAL NERVOUS SYSTEM

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15717358: METHODS TO TREAT MUCOPOLYSACCHARIDE TYPE II OR DEFICIENCY IN IDURONATE-2-SULFATASE USING A RECOMBINANT ADENO-ASSOCIATED VIRUS ENCODING IDURONATE-2-SULFATASE

(A1) 20180099030: METHODS TO TREAT MUCOPOLYSACCHARIDE TYPE II OR DEFICIENCY IN IDURONATE-2-SULFATASE USING A RECOMBINANT ADENO-ASSOCIATED VIRUS ENCODING IDURONATE-2-SULFATASE

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15813908: ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM

(A1) 20180071373: ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM

Assignee(s)